News Scan for Nov 04, 2014 CIDRAP
Sanofi Pasteur announced yesterday it will seek approval of its dengue virus vaccine in a number of dengue-plagued countries, following completion of a large phase 3 trial that showed overall vaccine efficacy of about 61%. The results of the trial, involving ...
Pharma firm makes headway in dengue vaccine trialsIndian Express
Dengue vaccine clears trials, may roll out in 2015Daily News & Analysis
World's 1st dengue vaccine likely by 2015: SanofiEconomic Times
all 66 news articles »
Sanofi Pasteur announced yesterday it will seek approval of its dengue virus vaccine in a number of dengue-plagued countries, following completion of a large phase 3 trial that showed overall vaccine efficacy of about 61%. The results of the trial, involving ...
Pharma firm makes headway in dengue vaccine trials
Dengue vaccine clears trials, may roll out in 2015
World's 1st dengue vaccine likely by 2015: Sanofi
Man gets brain pacemaker that can control his headache with remote control Daily News & Analysis
Picture this: The moment you experience a debilitating headache, you toggle controls on a remote hand-held device, and the shooting pain in your head disappears. Medical science makes this miraculous possibility real, but only for a particular condition ...
Jaslok doctors help Brit 'remote-control' his severe headachesMumbai Mirror
Brit gets operated at Mumbai hospital for rare neuro disorderHindustan Times
all 4 news articles »
Picture this: The moment you experience a debilitating headache, you toggle controls on a remote hand-held device, and the shooting pain in your head disappears. Medical science makes this miraculous possibility real, but only for a particular condition ...
Jaslok doctors help Brit 'remote-control' his severe headaches
Brit gets operated at Mumbai hospital for rare neuro disorder
Suven's new chemical entity enters phase-1 trial stage in US Times of India
HYDERABAD: Hyderabad-based biopharmaceutical player Suven Life Sciences informed the bourses that its new chemical entity (NCE) 'SUVN-3031' has commenced phase-1 clinical trial in the US. The NCE is used in the treatment of neurological disorders ...
Suven's new chemical entity enters clinical trial stage in USEconomic Times
Suven's new chemical entity enters clinical trialHindu Business Line
Suven commences Phase I trials of drug for Alzheimer's treatmentBusiness Standard
TheHealthSite
mydigitalfc.com
Myiris.com
all 15 news articles »
HYDERABAD: Hyderabad-based biopharmaceutical player Suven Life Sciences informed the bourses that its new chemical entity (NCE) 'SUVN-3031' has commenced phase-1 clinical trial in the US. The NCE is used in the treatment of neurological disorders ...
Suven's new chemical entity enters clinical trial stage in US
Suven's new chemical entity enters clinical trial
Suven commences Phase I trials of drug for Alzheimer's treatment
Making law to encourage organ transplant a complex issue: Ravi Shankar Prasad Zee News
New Delhi: Law Minister Ravi Shankar Prasad today said that formulating any law to encourage organ donation was a complex issue in view of the illegal rackets involved in it, especially the medical fraternity. "When I see this (law to encourage organ ...
Telecom Minister Pitches for Transparency in Organ Donations, Affordable ...Microfinance Monitor
India needs affordable healthcare: PrasadDeccan Herald
all 17 news articles »
New Delhi: Law Minister Ravi Shankar Prasad today said that formulating any law to encourage organ donation was a complex issue in view of the illegal rackets involved in it, especially the medical fraternity. "When I see this (law to encourage organ ...
Telecom Minister Pitches for Transparency in Organ Donations, Affordable ...
India needs affordable healthcare: Prasad
Wearable health device to track emotional health Jagran Post
New Delhi: You may soon have a wearable device that can track your emotional health. The Inner You (Inyu) health tracking device, which is all set to enter the emerging wearable gadget market, is capable to gauge ones emotion. Smokers more likely to ...
Indian researcher develops new device to track status of heartEconomic Times
all 18 news articles »
New Delhi: You may soon have a wearable device that can track your emotional health. The Inner You (Inyu) health tracking device, which is all set to enter the emerging wearable gadget market, is capable to gauge ones emotion. Smokers more likely to ...
Indian researcher develops new device to track status of heart
Biocon expands partnership with US-based CytoSorbents Business Standard
Biocon has expanded the scope of its strategic partnership with the US-based CytoSorbents Corporation for CytoSorb, a critical care drug. The Bangalore based biotechnology company had partnered with CytoSorbents in 2013 to launch CytoSorb, a therapy ...
Latest Insights on Cytosorbents Corp (OTCBB:CTSO)MicroCap Daily
Biocon expands strategic partnership with CytoSorbentsMyiris.com
Biocon CytoSorbents expand pact to treat body inflammationJagran Post
DigitalJournal.com
all 16 news articles »
Biocon has expanded the scope of its strategic partnership with the US-based CytoSorbents Corporation for CytoSorb, a critical care drug. The Bangalore based biotechnology company had partnered with CytoSorbents in 2013 to launch CytoSorb, a therapy ...
Latest Insights on Cytosorbents Corp (OTCBB:CTSO)
Biocon expands strategic partnership with CytoSorbents
Biocon CytoSorbents expand pact to treat body inflammation
Lupin recieves FDA's approval to market generic drug for arthritis in US TheHealthSite
Drug firm Lupin Ltd on Monday said it has received approval from the US Food and Drugs Administration (FDA) to market a generic version of GD Searle LLC's Celebrex capsules, used to treat arthritis, in the American market. The Mumbai-based company ...
Lupin gets USFDA nod for anti-arthritis medicineThe Hindu
Angel Broking maintains neutral on LupinMyiris.com
all 24 news articles »
Drug firm Lupin Ltd on Monday said it has received approval from the US Food and Drugs Administration (FDA) to market a generic version of GD Searle LLC's Celebrex capsules, used to treat arthritis, in the American market. The Mumbai-based company ...
Lupin gets USFDA nod for anti-arthritis medicine
Angel Broking maintains neutral on Lupin
Basic lingerie rules Northern Voices Online
As far as brassieres are concerned choose the right fit, rotate them and hand wash them, reports higgingtonpost.com. There are few general brassiere rules that most women probably don't know about. * Brassieres will never be a comfortable clothing item: ...
and more »
As far as brassieres are concerned choose the right fit, rotate them and hand wash them, reports higgingtonpost.com. There are few general brassiere rules that most women probably don't know about. * Brassieres will never be a comfortable clothing item: ...
MUSTRun 2014 to be held on December 14 India Education Diary
Mumbai: Mumbai's marathon season will be flagged off on December 14 with the 4th edition of MUSTRun. Organised by the H-West Federation, this year's MUSTRun is expected to see participation from serious runners, municipal school children, veterans, ...
Marathon season to begin on Dec. 14 with MUSTRunThe Asian Age
all 3 news articles »
Mumbai: Mumbai's marathon season will be flagged off on December 14 with the 4th edition of MUSTRun. Organised by the H-West Federation, this year's MUSTRun is expected to see participation from serious runners, municipal school children, veterans, ...
Marathon season to begin on Dec. 14 with MUSTRun
Working nights or odd hours can sap mental function, study finds Los Angeles Times
Working an irregular schedule that includes afternoon and night shifts can seriously sap your brain power, new research shows. For people who spent more than a decade on this type of rotating shift schedule, the effects were equivalent to 6.5 years of normal ...
Shift work may make people dumberAsiaOne
Working in abnormal shifts can impair brain power: StudyTimes of India
Shift work linked to brain power declineTelegraph.co.uk
Daily News & Analysis
CNN
Indian Express
all 205 news articles »
Working an irregular schedule that includes afternoon and night shifts can seriously sap your brain power, new research shows. For people who spent more than a decade on this type of rotating shift schedule, the effects were equivalent to 6.5 years of normal ...
Shift work may make people dumber
Working in abnormal shifts can impair brain power: Study
Shift work linked to brain power decline
沒有留言:
張貼留言